Treatment of the MPS NASH model with TGFβ and to a lesser extent fructose, could be used to model inflammation and fibrosis in NASH and potentially study the development of NASH-induced hepatocellular carcinoma, because TGFβ may be pro-carcinogenic50. The gene discussed is TGFB1; the disease is metabolic dysfunction-associated steatohepatitis.